In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


National uniformity delayed by lack of consensus in Senate Labor Cmte.

This article was originally published in The Rose Sheet

Executive Summary

NATIONAL UNIFORMITY LANGUAGE NOT INCLUDED IN SENATE FDA REFORM LEGISLATION as introduced by Labor & Human Resources Committee Chairman James Jeffords (R-Vt.) June 5. The provision, which would allow FDA regulations to transcend local and state governments' safety and labeling statutes for cosmetics and over-the-counter drugs, was expected to be included in the first draft of S 830. At a May 28 press briefing, the committee noted that although specific national uniformity language had not yet been written, the measure was still of high interest and was under development ("The Rose Sheet" June 2, p. 10).



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts